Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Meningococcal Vaccination

Vaccines help protect against all three serogroups (B, C, and Y) of meningococcal disease commonly seen in the United States:

  • Meningococcal conjugate vaccines (Menactra® and Menveo®)
  • Serogroup B meningococcal vaccines (Bexsero® and Trumenba®)

What Everyone Should Know about Meningococcal Vaccines

Information on Meningococcal Vaccine Recommendations

Q&A image

In addition to meningococcal conjugate vaccination, clinicians may choose to administer a serogroup B meningococcal vaccine to patients 16 through 23 years old. Get information about these vaccine recommendations.

Meningococcal Vaccination: Information for Healthcare Professionals

Vaccination Coverage

Top of Page

Related Pages